← SynDRA
DERAZANTINIB
SynDRA canonical compound SYN0039412 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | FGF2 | FGFR1 | FGFR2 | FGFR3 |
|---|
| Mechanism of action | tyrosine kinase inhibitor |
|---|
All known targets
- FGFR1
- FGFR2
- FGFR3
- FGF2
- FGFR4
Mechanisms of action (all sources)
- FGFR3 INHIBITOR
- Fibroblast growth factor receptor inhibitor
- FGFR1 INHIBITOR
- FGFR4 INHIBITOR
- FGFR2 INHIBITOR
- tyrosine kinase inhibitor
Cross-references
Synonyms
- ARQ 087
- ARQ087
- N9B0H171MJ
- derazantinibum
- RefChem:132048
- Derazantinib [USAN]
- Derazantinib(ARQ-087)
- Derazantinib (ARQ 087)
- C29H29FN4O
- MFCD30532770
- DERAZANTINIB [INN]
- UNII-N9B0H171MJ
- DERAZANTINIB [WHO-DD]
- GTPL9785
- orb1296116
- SCHEMBL13273847
- SCHEMBL29357382
- SCHEMBL29360271
- SCHEMBL29366359
- EX-A1717
- s8609
- WHO 10488
- AKOS037648596
- CS-7922
- NCGC00509932-02
- AC-30343
- BS-14785
- HY-19981
- SY235567
- DB-210790
- C71924
- F861615
- (6R)-6-(2-fluorophenyl)-N-[3-[2-(2-methoxyethylamino)ethyl]phenyl]-5,6-dihydrobenzo[h]quinazolin-2-amine
- ARQ 087.2HCl
- Derazantinib hydrochloride
- Derazantinib Hydrochloride
- Derazantinib dihydrochlororide
- SCHEMBL29414565
- orb1739337
Look up DERAZANTINIB in the interactive SynDRA portal →